PerfWeb 98 continues its educational journey into Day 2, focusing on the pivotal aspects of Extracorporeal Life Support (ECLS) and its adverse effects. Scheduled for Tuesday, March 19, 2024, this session is a crucial convergence for perfusionists, offering deep dives into the complexities and challenges associated with ECLS treatments. Endorsed with 1.2 Category 1 CEUs by the American Board of Cardiovascular Perfusion (ABCP), this seminar underscores the commitment to providing cutting-edge education and fostering a deeper understanding of critical care in perfusion practices. Event Overview Date: Tuesday, March 19, 2024 Time: 1700-1900 PerfWeb 98—Day 2 is singularly designed to enrich the knowledge base of perfusionists with a comprehensive exploration of ECLS. This session aims to equip professionals with the insights needed to navigate the adverse effects of ECLS, enhancing patient care and outcomes. The seminar is an essential platform for those in the field seeking to bolster their expertise, stay updated with the latest research, and engage in meaningful discussions on overcoming ECLS challenges. Session Details Adverse Effects of ECLS Faculty: V. Carlyle, RN, BSN-CCRN The session will be led by V. Carlyle, RN, BSN-CCRN, a distinguished figure in the field of critical care nursing with extensive experience in ECLS. Carlyle’s presentation is set to cover the gamut of potential adverse effects associated with ECLS, including but not limited to thrombosis, bleeding, infection, and neurological complications. The session aims to not only outline these challenges but also to delve into preventive strategies, management techniques, and the latest research findings that can help mitigate these adverse effects. Participants will have the opportunity to engage in an interactive discussion, sharing experiences, strategies, and questions related to ECLS complications. This collaborative environment is designed to foster a community of learning and support among perfusionists and critical care professionals. CEU Accreditation This session has received the approval of 1.2 Category 1 CEUs by the ABCP, validating its educational merit and relevance to the perfusion community. This accreditation ensures that participants are recognized for their dedication to advancing their knowledge and skills, contributing to their professional development and the quality of care provided to patients. Why Attend? Expert Insights: Gain valuable knowledge from an experienced professional in the field of critical care and ECLS, enhancing your understanding of the adverse effects and management strategies. CEU Accreditation: Earn 1.2 Category 1 CEUs approved by the ABCP, supporting your professional development and maintaining your certification. Collaborative Learning: Benefit from the shared experiences and strategies of peers, enriching your practice and problem-solving skills. Critical Updates: Stay informed on the latest research and developments in ECLS, ensuring your practice is aligned with current standards and best practices. Registration and Participation Advance registration is encouraged for those planning to attend PerfWeb 98—Day 2. Complete details on how to register, including any associated fees, can be found on the official event website. Participants will also have access to post-event session recordings, offering flexibility in engaging with the material at their convenience. PerfWeb 98—Day 2 is an indispensable opportunity for perfusionists to deepen their understanding of ECLS, confront its adverse effects, and explore innovative solutions for enhancing patient outcomes. This seminar promises to be a valuable addition to the educational calendar of any perfusionist committed to excellence in their field. Join us on March 19, 2024, to partake in an educational experience that will shape the future of perfusion practices and patient care across North America.
The New Orleans Conference 2017 Houston Edition — Perfusion and the Law: From Soup to Nuts — Perfusion
The New Orleans Conference 2017 Las Vegas Edition — The Other Guys Tool Box. Survival Through Diversification — Perfusion
The New Orleans Conference 2017 Las Vegas Edition — Nontuberculous Mycobacteria (NTM) What are the facts? — Perfusion
The New Orleans Conference 2017 Las Vegas Edition — Line Placement In The Current Era - State Of The Art — Perfusion
The New Orleans Conference 2017 Las Vegas Edition — Infections In Cardiac Surgery - How Prevalent Is This? — Perfusion
The New Orleans Conference 2017 Las Vegas Edition — Future Trends In Mechanical Support — Perfusion
Joe Basha‘s PerfWeb C30 — Primary differences between Roller vs Centrifugal Arterial Pumps - How They Work — Perfusion
Joe Basha‘s PerfWeb C30 — Point of care (POC) laboratory analysis for perfusion - POC Devices — Perfusion
The New Orleans Conference 2019 Online Edition – Day 3
The New Orleans Conference 2019 Online Edition – Day2
The New Orleans Conference 2019 Online Edition – Day 1
Joe Basha‘s PerfWeb #17 Full Program — Pediatric perfusion refresher for the adult perfusionist — Perfusion
Joe Basha‘s PerfWeb #15 Full Program — Charting-Electronic Charting-LivaNova Connect — Perfusion
Joe Basha‘s PerfWeb C30 — PH Stat and Alpha stat. Blood Gas Management — Perfusion
Joe Basha‘s PerfWeb #21 — Understanding how TEG works and interpreting the graphs. Thromboelastograghy. — Perfusion
Joe Basha‘s PerfWeb #19 — Novel Anticoagulants. Hemostasis Post Cardiopulmonary Bypass. Unique challenges associated with them in the cardiac surgery patient — Perfusion
Joe Basha‘s PerfWeb #6 Full Program — Cardioplegia: Extracorporeal Membrane Oxygenation ECMO Patient Selection — Perfusion
Joe Basha‘s PerfWeb C30 — Perfusion Job - Perfusionist Career - Perfusion Education — Perfusion
Joe Basha‘s PerfWeb C30 — Passive antibody therapy in the treatment of COVID-19 — Perfusion
Joe Basha‘s PerfWeb C30 — Novel Approach for Treating Vasoplegia Syndrome and Shock — Perfusion
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive